Yehuda Handelsman

Summary

Country: USA

Publications

  1. pmc Bile acid sequestrants for lipid and glucose control
    Bart Staels
    Institut Pasteur de Lille, 1 rue Calmette BP245, 59019, Lille Cedex, France
    Curr Diab Rep 10:70-7. 2010
  2. doi request reprint Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?
    Yehuda Handelsman
    Metabolic Institute of America, 18372 Clark Street, Suite 212, Tarzana, CA 91356, USA
    Expert Rev Clin Pharmacol 5:43-54. 2012
  3. doi request reprint Overcoming obstacles in risk factor management in type 2 diabetes mellitus
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    J Clin Hypertens (Greenwich) 13:613-20. 2011
  4. doi request reprint Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    Postgrad Med 121:62-9. 2009
  5. doi request reprint The role of colesevelam HCl in type 2 diabetes mellitus therapy
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    Postgrad Med 121:19-24. 2009
  6. doi request reprint Metabolic syndrome pathophysiology and clinical presentation
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, California 91356, USA
    Toxicol Pathol 37:18-20. 2009
  7. ncbi request reprint Treating diabetes with incretin hormones - clinical experience
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    Pediatr Endocrinol Rev 5:897-903. 2008
  8. doi request reprint Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, California 91356, USA
    Endocr Pract 16:617-28. 2010
  9. doi request reprint Pharmacologic treatment options for prediabetes
    Willa A Hsueh
    Diabetes Research Center, Division of Diabetes, Obesity and Lipids, Methodist Hospital Research Institute, Houston, TX 77030, USA
    Nat Clin Pract Endocrinol Metab 4:380-1. 2008
  10. ncbi request reprint Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force
    Paul S Jellinger
    Endocr Pract 13:260-8. 2007

Collaborators

Detail Information

Publications13

  1. pmc Bile acid sequestrants for lipid and glucose control
    Bart Staels
    Institut Pasteur de Lille, 1 rue Calmette BP245, 59019, Lille Cedex, France
    Curr Diab Rep 10:70-7. 2010
    ....
  2. doi request reprint Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?
    Yehuda Handelsman
    Metabolic Institute of America, 18372 Clark Street, Suite 212, Tarzana, CA 91356, USA
    Expert Rev Clin Pharmacol 5:43-54. 2012
    ....
  3. doi request reprint Overcoming obstacles in risk factor management in type 2 diabetes mellitus
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    J Clin Hypertens (Greenwich) 13:613-20. 2011
    ..Overcoming the obstacles to achieving treatment targets may include use of strategies such as early intensive treatment and combination therapy with drugs with complementary mechanisms of action...
  4. doi request reprint Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    Postgrad Med 121:62-9. 2009
    ..In patients with hyperlipidemia and prediabetes, colesevelam HCl improved glycemic control and the lipid profile...
  5. doi request reprint The role of colesevelam HCl in type 2 diabetes mellitus therapy
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    Postgrad Med 121:19-24. 2009
    ..This article reviews the place of colesevelam HCl in therapy (both for T2DM and prediabetes), the benefits of early, intensive treatment of T2DM, and the importance of safe glycemic control later in the disease process...
  6. doi request reprint Metabolic syndrome pathophysiology and clinical presentation
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, California 91356, USA
    Toxicol Pathol 37:18-20. 2009
    ..Lately medications--though none approved by the U.S. Food and Drug Administration (FDA)--have been recommended by major medical societies when lifestyle modification is not enough or when it fails...
  7. ncbi request reprint Treating diabetes with incretin hormones - clinical experience
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, CA 91356, USA
    Pediatr Endocrinol Rev 5:897-903. 2008
    ..Recently several compounds became available for treatment. This is a review of incretin mimetics and enhancers and their clinical utility...
  8. doi request reprint Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study
    Yehuda Handelsman
    Metabolic Institute of America, Tarzana, California 91356, USA
    Endocr Pract 16:617-28. 2010
    ..To assess the effect of the bile acid sequestrant colesevelam hydrochloride in patients with hypercholesterolemia and prediabetes...
  9. doi request reprint Pharmacologic treatment options for prediabetes
    Willa A Hsueh
    Diabetes Research Center, Division of Diabetes, Obesity and Lipids, Methodist Hospital Research Institute, Houston, TX 77030, USA
    Nat Clin Pract Endocrinol Metab 4:380-1. 2008
  10. ncbi request reprint Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force
    Paul S Jellinger
    Endocr Pract 13:260-8. 2007
  11. ncbi request reprint Hypoglycemia in the intensive care unit
    Jeffrey I Mechanick
    Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, New York 10128, USA
    Curr Opin Clin Nutr Metab Care 10:193-6. 2007
    ..To review recent articles and evaluate hypoglycemia as a major complication of intensive insulin therapy in anticipation of emerging data from current clinical studies...
  12. ncbi request reprint American College of Endocrinology position statement on the insulin resistance syndrome
    Daniel Einhorn
    American College of Endocrinology
    Endocr Pract 9:237-52. 2003